These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 27338009)
1. Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies. Napolitano M; Di Minno MN; Batorova A; Dolce A; Giansily-Blaizot M; Ingerslev J; Schved JF; Auerswald G; Kenet G; Karimi M; Shamsi T; Ruiz de Sáez A; Dolatkhah R; Chuansumrit A; Bertrand MA; Mariani G Haemophilia; 2016 Sep; 22(5):752-9. PubMed ID: 27338009 [TBL] [Abstract][Full Text] [Related]
2. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency. Brenner B; Wiis J Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994 [TBL] [Abstract][Full Text] [Related]
3. Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER. Mariani G; Dolce A; Batorova A; Auerswald G; Schved JF; Siragusa S; Napolitano M; Knudsen JB; Ingerslev J; Br J Haematol; 2011 Feb; 152(3):340-6. PubMed ID: 21158750 [TBL] [Abstract][Full Text] [Related]
4. Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation. Mariani G; Napolitano M; Dolce A; Pérez Garrido R; Batorova A; Karimi M; Platokouki H; Auerswald G; Bertrand AM; Di Minno G; Schved JF; Bjerre J; Ingerslev J; Sørensen B; Ruiz-Saez A; ; Thromb Haemost; 2013 Feb; 109(2):238-47. PubMed ID: 23238632 [TBL] [Abstract][Full Text] [Related]
5. Surgery in patients with congenital factor VII deficiency - a single center study. Szczepanik A; Wiszniewski A; Oses-Szczepanik A; Dąbrowski W; Pielaciński K; Misiak A Pol Przegl Chir; 2018 May; 90(5):1-5. PubMed ID: 30426948 [TBL] [Abstract][Full Text] [Related]
6. Management of factor VII-deficient patients undergoing joint surgeries--preliminary results of locally developed treatment regimen. Windyga J; Zbikowski P; Ambroziak P; Baran B; Kotela I; Stefanska-Windyga E Haemophilia; 2013 Jan; 19(1):89-93. PubMed ID: 22845882 [TBL] [Abstract][Full Text] [Related]
7. Factor VII deficiency: defining the clinical picture and optimizing therapeutic options. Lapecorella M; Mariani G; Haemophilia; 2008 Nov; 14(6):1170-5. PubMed ID: 19141157 [TBL] [Abstract][Full Text] [Related]
8. Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal. Mariani G; Konkle BA; Ingerslev J Haemophilia; 2006 Jan; 12(1):19-27. PubMed ID: 16409171 [TBL] [Abstract][Full Text] [Related]
9. Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency. Di Minno MN; Dolce A; Mariani G; Thromb Haemost; 2013 Jun; 109(6):1051-9. PubMed ID: 23571462 [TBL] [Abstract][Full Text] [Related]
10. Prevention of bleeding and hemorrhagic complications in surgical patients with inherited factor VII deficiency. Wiszniewski A; Szczepanik A; Misiak A; Bykowska K; Szopiński P Blood Coagul Fibrinolysis; 2015 Apr; 26(3):324-30. PubMed ID: 25688458 [TBL] [Abstract][Full Text] [Related]
11. Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER). Napolitano M; Giansily-Blaizot M; Dolce A; Schved JF; Auerswald G; Ingerslev J; Bjerre J; Altisent C; Charoenkwan P; Michaels L; Chuansumrit A; Di Minno G; Caliskan U; Mariani G Haematologica; 2013 Apr; 98(4):538-44. PubMed ID: 23403322 [TBL] [Abstract][Full Text] [Related]
12. Is prophylaxis required for delivery in women with factor VII deficiency? Baumann Kreuziger LM; Morton CT; Reding MT Haemophilia; 2013 Nov; 19(6):827-32. PubMed ID: 23607277 [TBL] [Abstract][Full Text] [Related]
14. Primary prophylaxis for children with severe congenital factor VII deficiency - Clinical and laboratory assessment. Kuperman AA; Barg AA; Fruchtman Y; Shaoul E; Rosenberg N; Kenet G; Livnat T Blood Cells Mol Dis; 2017 Sep; 67():86-90. PubMed ID: 28038846 [TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients. van Geffen M; Mathijssen NC; Holme PA; Laros-van Gorkom BA; van Kraaij MG; Masereeuw R; Peyvandi F; van Heerde WL Thromb Res; 2013 Jul; 132(1):116-22. PubMed ID: 23731565 [TBL] [Abstract][Full Text] [Related]
16. A new perspective on perioperative coagulation management in a patient with congenital factor VII deficiency: A case report. Sun Y; Jia L; Yang Z; Chen W Medicine (Baltimore); 2018 Nov; 97(44):e12776. PubMed ID: 30383632 [TBL] [Abstract][Full Text] [Related]
17. Long-term prophylaxis in severe factor VII deficiency. Siboni SM; Biguzzi E; Mistretta C; Garagiola I; Peyvandi F Haemophilia; 2015 Nov; 21(6):812-9. PubMed ID: 25952977 [TBL] [Abstract][Full Text] [Related]
18. A comprehensive review of rFVIIa use in a tertiary care pediatric center. Heller M; Lau W; Pazmino-Canizares J; Brandão LR; Carcao M Pediatr Blood Cancer; 2008 May; 50(5):1013-7. PubMed ID: 17960639 [TBL] [Abstract][Full Text] [Related]
19. Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath. Karimi M Semin Hematol; 2008 Apr; 45(2 Suppl 1):S74. PubMed ID: 18544432 [TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of prophylaxis with recombinant activated factor VII in patients with congenital factor VII deficiency. Jenabali Jahromi B; Karimi M Haemophilia; 2011 Jul; 17(4):713-5. PubMed ID: 21299748 [No Abstract] [Full Text] [Related] [Next] [New Search]